Filing Details
- Accession Number:
- 0001209191-10-032001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-03 13:00:00
- Reporting Period:
- 2010-06-01
- Filing Date:
- 2010-06-03
- Accepted Time:
- 2010-06-03 17:05:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1047699 | King Pharmaceuticals Inc | KG | Pharmaceutical Preparations (2834) | 541684963 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213334 | Charles Moyer | C/O King Pharmaceuticals, Inc. 501 Fifth Street Bristol TN 37620 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-06-01 | 7,000 | $8.57 | 32,213 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2010.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.52 to $8.611, inclusive. The reporting person has provided to King Pharmaceuticals, Inc., and will provide upon request to any security holder of King Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
